Business Wire

ASYMCHEM

Share
Asymchem Appoints Dr. Cheng Yi Chen as CTO of Small-Molecule Sector

In line with Asymchem’s continuous strategic layout and development, the organization has welcomed Dr. Cheng Yi Chen as a senior executive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626665787/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Asymchem is pleased to announce Dr. Cheng Yi Chen has joined Asymchem as Small-Molecule Sector CTO. (Photo: Business Wire)

Dr. Cheng Yi Chen officially joined Asymchem as CTO of the Small-Molecule Sector on June 18, 2024. He will report directly to Asymchem’s CEO, Dr. Hao Hong. In this position, Dr. Cheng Yi Chen will provide technical support to the group’s chemical small molecule sales in the European and United States markets. His main duties include active participation in technical communications for key mid-to-late-stage clinical projects in Europe and United States and facilitating collaborations with crucial new clients by capitalizing on the overall technical capabilities of the group’s chemical small-molecule sector. He will also offer guidance to the China Core Team on project-related technical matters with European and United States clientele and provide advisory input for communication. Additionally, he will provide technical expertise suggestions for the Boston site in the United States, as well as supervising technical operations at small-molecule laboratories and pilot production sites across Europe.

Dr. Chen worked at Merck Research Laboratories, Janssen Pharmaceuticals of Johnson & Johnson, Mirati Therapeutics, and Bristol Myers Squibb before joining Asymchem. He has extensive experience designing, developing, and implementing robust, cost-effective, and green manufacturing routes for small molecule APIs, ensuring CMC compliance and quality, collaborating with cross-functional drug development teams and external partners, and supporting regulatory filings. Dr. Chen received his Ph.D. in organic chemistry from The Ohio State University.

About Asymchem

Asymchem is a comprehensive contract development and manufacturing organization (CDMO) with a complete continuum of support from preclinical to commercialization. Founded in 1997, Asymchem offers integrated solutions spanning the entire drug substance and drug product life cycle, backed by cutting-edge technology including flow chemistry and green manufacturing. With R&D and manufacturing operations in China, Europe, and the U.S. and a team of proven experts, we provide a full range of CDMO services for a global client base.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240626665787/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Tholos Foundation Reveals Critical Risks of Proposed Nicotine Pouch Regulations4.12.2024 22:01:00 CET | Press release

The Tholos Foundation, in collaboration with IPSOS & HBS Economics, today released groundbreaking research exposing the risks of the proposed Danish regulations limiting nicotine content in nicotine pouches to 9 mg per pouch. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204248551/en/ Key findings highlight significant public health and economic concerns The comprehensive study reveals alarming potential outcomes if the proposed nicotine limit is implemented: Consumer behavior shifts Half (50%) of current nicotine pouch users would seek alternative purchasing channels, either online or across the border of other EU countries One in five (18%) users might return to smoking Proposed limit threatens Denmark's remarkable progress in reducing smoking rates from 19% to 14% between 2018 and 2023** Public health implications 3 out of 4 (75%) users originally chose nicotine pouches for health-related reasons, primarily to reduce

Andersen Global udvider sin dækning af Filippinerne med Gravitas Prime4.12.2024 21:46:00 CET | Pressemeddelelse

Andersen Global indleder yderligere ekspansion i Asien og Stillehavsområdet gennem en samarbejdsaftale med Gravitas Prime, der arbejder med fusioner og overtagelser i Filippinerne. Gravitas Prime blev grundlagt i 2005 af daværende bestyrelsesformand Ed David, og tilbyder en omfattende pakke af tjenester, herunder fusioner og overtagelser, virksomhedsstrategi, værdiansættelse af virksomheder, ejendomsplanlægning og kapitalrejsning. Firmaet driver strategiske initiativer for et forskelligartet kundegrundlag. Det råder over specialiseret ekspertise inden for forbruger, detailhandel, mad og drikkevarer, QSR, lægemidler og sundhedspleje, hotel-, restaurations- og oplevelsesbranchen, energi og vedvarende energikilder. Gravitas Prime har opbygget stærke relationer med en bred vifte af strategiske investorer, herunder familiekontorer, førende selskabskonglomerater og private equity-selskaber. "Her i firmaet har vi altid fokuseret på værdiforøgelse, på at drive vækst og identificere muligheder

Almirall Launches The Hive, Creating a Novel Collaborative Innovation Hub to Advance Life Sciences and Healthcare4.12.2024 16:58:00 CET | Press release

80th anniversary commemorative eventsThe Hive is aimed at advancing research in life sciences by a novel approach to collaboration - creating an open innovation hub designed to build close relationships between biotech companies, start-ups, academics, and Almirall scientistsThe network will be enlarged with the arrival of Admit Therapeutics and Microomics, in addition to the current members of the hub ZeClinics and Centrient PharmaceuticalsThis novel approach to pushing the boundaries of science and innovation in the year of Almirall’s 80th anniversary is part of the company’ s innovation strategy, long-term vision, commitment to patients, and the advancement of healthcare Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of “The Hive”, a novel scientific research hub located at its R&D centre in Barcelona, Spain. The Hive is designed to foster collaboration among researchers from biotech companies, start-ups, academia, and Almirall’

Now Is the Time To Host Events in Japan, With the Yen at a Low! Global Produce Launches Full-Scale Production of “Event Hosting in Japan” for Overseas Companies4.12.2024 16:00:00 CET | Press release

Providing English support, potential venues such as arenas and historic buildings, and more—a team of event professionals bringing unique, extraordinary, and emotional events to life! Global Produce Co., Ltd. (Head Office: Shibuya Ward, Tokyo; CEO: Masaki Kouhata; hereinafter referred to as “Global Produce”), a company specializing in event production, is pleased to announce the full-scale launch of its production services for overseas companies looking to host events in Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121186571/en/ Global Produce Launches Full-Scale Production of “Event Hosting in Japan” for Overseas Companies (Graphic: Business Wire) With Global Produce, your dream event in Japan can become a reality! Our “Japan Event Hosting Plan” was created to bring the visions of overseas companies to life using events hosted in Japan. Not only will native speakers be present at the forefront, but our producers

DataXstream Launches OMS+ Cloud for SAP S/4HANA Cloud Public Edition4.12.2024 15:03:00 CET | Press release

The newest product offering delivers B2B point of sales and order management capabilities to SAP Public Cloud Users Worldwide DataXstream LLC, an SAP® Endorsed app and Gold-level partner developing innovative solutions for SAP sales and distribution, today introduced OMS+ Cloud for SAP S/4HANA Cloud Public Edition. OMS+ has streamlined complex sales and order processes for SAP users for over a decade within SAP ECC and S/4HANA Cloud Private Edition environments. But recent forecast numbers from Gartner show that worldwide spending on public cloud services is increasing significantly and will reach a total of $723.4 billion in 2025, with a 19% growth increase in Cloud Application Services (SaaS). (Source: Gartner, November 2024) DataXstream’s OMS+ Cloud will now extend its award-winning OMS+ platform by delivering end-to-end point of sales (POS) and order management capabilities for SAP Public Cloud. OMS+ Cloud will simplify complex POS, quote and order processes often associated with v

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye